Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

NCT01282476 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
18
Enrollment
OTHER
Sponsor class

Stopped slow accrual

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators